Search results
Results from the WOW.Com Content Network
The 2010 Johnson & Johnson children's product recall involved 43 over-the-counter children's medicines announced by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, on April 30, 2010. Medications in the recall included liquid versions of Tylenol, Tylenol Plus, Motrin, Zyrtec, and Benadryl. The products were recalled after it was ...
Recalls of Tylenol, Motrin and Benadryl might have received the most attention, but they were just part of the story as recalls of over-the-counter (OTC) and prescription drugs quadrupled in 2009 ...
Generic drug manufacturers often change the way in which prescription drug ingredients are made in order to lower costs of making them, so this kind of contamination may be more widespread and undetected in generic drugs. [21] 2022–2023 United States P. aeruginosa outbreak in eye drops
Data from Drug Overdose Mortality by State. Pick year from menu below map. From National Center for Health Statistics for the Centers for Disease Control and Prevention. The numbers are in the data table below the map, and by running your cursor over the map at the source. Also from "Download Data (CSV)" link below the map. Author
Top Food and Drug Administration officials told a congressional committee today that Johnson & Johnson, the venerable manufacturer of Children's Tylenol, Motrin, Benadryl and other children's ...
The Food and Drug Administration is reportedly investigating reports of at least 775 serious side effects from drugs recalled by McNeil Consumer Healthcare, a division of Johnson & Johnson ...
Johnson & Johnson initiated one of the largest drug recalls in history on Oct. 5, 1982, when it withdrew Tylenol from the market in response to a rash of murderous package tampering that.
A drug recall removes a prescription or over-the-counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall. [1]